Virginia Retirement Systems
MDGL icon

Virginia Retirement Systems’s Madrigal Pharmaceuticals MDGL Stock Holding History

Virginia Retirement Systems’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.03M Buy
2,040
+240
+13% +$127K 0.01% 724
2026
Q2 		$967K Buy
1,800
+960
+114% +$492K 0.01% 776
2026
Q1 		$440K Buy
840
+40
+5% +$19.1K ﹤0.01% 789
2025
Q4 		$466K Buy
+800
New +$409K ﹤0.01% 771

Other funds holding MDGL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Virginia Retirement Systems's MDGL Position: Q3 2026 in Review

Virginia Retirement Systems increased its Madrigal Pharmaceuticals (MDGL) stake by 13% in Q3 2026, buying an estimated $127K and bringing the position to 2,040 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #724.

Virginia Retirement Systems first reported a position in MDGL in Q4 2025 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Virginia Retirement Systems held 2,040 shares of Madrigal Pharmaceuticals worth $1.03M as of Q3 2026.
  • Virginia Retirement Systems bought 240 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $127K.
  • Madrigal Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #724 holding.
  • Virginia Retirement Systems first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.